456NewsSingapore’s company incorporation expert, Think SME, expands service into Hong Kong and China
Amid increasing demand and political instability in Hong Kong and China, Think SME’s expansion promises affordable but expert support for foreign business...
- 478Wire Stories
CalAmp Appoints Chris Adams as President and Chief Executive Officer
Company hires technology veteran to accelerate its transformation and drive profitable growth IRVINE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) — CalAmp (Nasdaq:...
- 461Wire Stories
Australia & New Zealand Fleet Management Report 2024 – Installed Base of Fleet Management Systems in Australia and New Zealand to Exceed 2.4 Million Units by 2027 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Fleet Management in Australia & New Zealand – 8th Edition” report has been added to ResearchAndMarkets.com’s offering. The report analyses...
- 415Wire Stories
HighField Biopharmaceuticals HF1K16 Phase 1a Data Suggests the New Immuno-Oncology Drug is Safe, Well-Tolerated and Efficacious in Solid Tumors
HANGZHOU, China–(BUSINESS WIRE)–HighField Biopharmaceuticals, a clinical stage immuno-oncology company using lipid-based therapeutics to treat cancer, announced today it has completed its Phase...
- 463Wire Stories
FPT Software and Fivetran Forge Strategic Alliance to Drive Cloud and Data Integration
HANOI, Vietnam–(BUSINESS WIRE)–#FPT–Global leading IT firm FPT Software and Fivetran, the global leader in data integration, have formed a strategic partnership to...
- 559News
Fajarbaru Land Forms Joint Venture for Seremban Project Worth RM172.4m
KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 8 January 2024 – Fajarbaru Land (M) Sdn Bhd has entered into a joint...
- 518Wire Stories
Biocytogen Enters into Bispecific Antibody Drug Conjugate Agreement with Radiance Biopharma
BEIJING & BOSTON–(BUSINESS WIRE)–#ADC–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogenâ€, HKEX: 02315), a global biotech company focusing on the discovery of novel antibody...
- 615Wire Stories
Aptia, Leading New Pensions and Employee Health and Benefits Specialist, Formally Launches with 1,100 Clients and Supporting 7 Million People
LONDON & BOSTON–(BUSINESS WIRE)–Aptia (the “Companyâ€), a dedicated pension, health and benefits administration specialist, today announced its formal launch with 1,100 global...
- 409Wire Stories
Inotrem Successfully Reaches Agreement with the FDA for a Phase 3 Registration Trial for Nangibotide in Septic Shock
Novel biomarker-guided Phase 3 registration trial in septic shock with an enrichment strategy-based patient selection. Historic paradigm shift in Primary endpoint: from...
- 402Wire Stories
B2C2 Appoints Thomas Restout as Group CEO
LONDON & TOKYO & JERSEY CITY, N.J.–(BUSINESS WIRE)–#B2C2–B2C2, the leading institutional digital asset liquidity provider, today announces that Thomas Restout has been...
